CXCR4 and neoplasm: Furthermore, through encapsulation of chemotherapeutic drug doxorubicin (Dox) into M-E5, we found that M-E5 was capable of sensitizing tumor cells for Dox in vitro via blocking CXCR4/CXCL12 axis.